IGFBP2 and central nervous system cancer: However, larger published studies have linked IGFBP‐2 with prognosis in glioma, as a prognostic biomarker and therapeutic target both in tissue14, 15, 33, 34, 35, 36 and plasma.20, 21, 37, 38